title: Preventative treatment in an animal model of ADHD: Behavioral and biochemical effects of methylphenidate and its interactions with ovarian hormones in female rats.
abstract: Clinical and preclinical studies on attention deficit hyperactivity disorder (ADHD) show that juvenile males that are exposed to methylphenidate (MPH) show reduced risk for substance use later in life. In contrast, little is known about whether females have the same enduring treatment response to stimulants and how gonadal hormones influence their behavior later in life. Females received either a sham or 6-hydroxydopamine (6-OHDA) microinjection in the prefrontal cortex (PFC) at postnatal day (P)10. Subjects were then treated with Vehicle or MPH (2mg/kg, p.o.) between P20-35 and tested during late adolescence/young adulthood (P60); half of these subjects underwent ovariectomy at P55 to determine hormonal influences. Females with 6-OHDA were depleted of PFC dopamine by 61% and demonstrated increased impulsive choice (delayed discounting) and preferences for cocaine-associated environments relative to control females. Both MPH and ovariectomy reduced impulsive choice and cocaine preferences in 6-OHDA females, but had no enduring effect in Sham females. Ovariectomy itself did not significantly affect impulsivity. Juvenile MPH interacted strongly with 6-OHDA to increase D4, D5, Alpha-1A, Alpha-2A, and 5-HT-1A mRNA receptor expression in the PFC. MPH alone effected D1 mRNA, while 6-OHDA increased BDNF; all markers were decreased by ovariectomy. Together, these data suggest that 6-OHDA changes in dopamine are not only relevant for ADHD-like behaviors, but their long-term modulation by treatment and the influence of cyclical differences in menstrual cycle.
authors.affiliation: Laboratory for Developmental Neuropharmacology, McLean Hospital, USA; Harvard Medical School, USA.
authors.forename: Jodi L
authors.initials: JL
authors.lastname: Lukkes
authors.affiliation: Laboratory for Developmental Neuropharmacology, McLean Hospital, USA; Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.
authors.forename: Nadja
authors.initials: N
authors.lastname: Freund
authors.affiliation: Laboratory for Developmental Neuropharmacology, McLean Hospital, USA.
authors.forename: Britta S
authors.initials: BS
authors.lastname: Thompson
authors.affiliation: Laboratory for Developmental Neuropharmacology, McLean Hospital, USA.
authors.forename: Shirisha
authors.initials: S
authors.lastname: Meda
authors.affiliation: Laboratory for Developmental Neuropharmacology, McLean Hospital, USA; Harvard Medical School, USA. Electronic address: sandersen@mclean.harvard.edu.
authors.forename: Susan L
authors.initials: SL
authors.lastname: Andersen
mesh_terms: D000818:Animals; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000378:metabolism*; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D003042:Cocaine / Q000494:pharmacology; D003213:Conditioning, Psychological / Q000187:drug effects / Q000502:physiology; D065786:Delay Discounting / Q000187:drug effects / Q000502:physiology; D004195:Disease Models, Animal; D004298:Dopamine / Q000378:metabolism; D005260:Female; D042341:Gonadal Hormones / Q000378:metabolism*; D007175:Impulsive Behavior / Q000187:drug effects / Q000502:physiology; D008774:Methylphenidate / Q000494:pharmacology*; D010052:Ovariectomy; D016627:Oxidopamine; D017397:Prefrontal Cortex / Q000187:drug effects / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D017207:Rats, Sprague-Dawley; D017981:Receptors, Neurotransmitter / Q000378:metabolism
chemical_list: D000697:Central Nervous System Stimulants; D042341:Gonadal Hormones; D012333:RNA, Messenger; D017981:Receptors, Neurotransmitter; D008774:Methylphenidate; D016627:Oxidopamine; D003042:Cocaine; D004298:Dopamine
keywords: BDNF; Discounting; Dopamine; Estrogen; Impulsive choice; Norepinephrine